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https://doi.org/10.1016/j.stemcr.2019.02.011SUMMARYTissue-specific stem cells have unique properties and growth requirements, but a small set of juxtacrine and paracrine signals have been
identified that are required acrossmultiple niches.Whereas insulin-like growth factor II (IGF-II) is necessary for prenatal growth, its role in
adult stem cell physiology is largely unknown. We show that loss of Igf2 in adult mice resulted in a 50% reduction in slowly dividing,
label-retaining cells in the two regions of the brain that harbor neural stem cells. Concordantly, induced Igf2 deletion increased newly
generated neurons in the olfactory bulb accompanied by hyposmia, and caused impairments in learning andmemory and increased anx-
iety. Induced Igf2 deletion also resulted in rapid loss of stem and progenitor cells in the crypts of Lieberku¨hn, leading to body-weight loss
and lethality and the inability toproduceorganoids in vitro. Thesedatademonstrate that IGF-II is critical formultiple adult stemcellniches.INTRODUCTION
Stem cells have long been of interest to developmental bi-
ologists; however, these cells have now gained the interest
of the broader scientific community because of their poten-
tial to repair degenerating tissues. For example, neural stem
cells (NSCs) and the new neurons that they produce are
now recognized as necessary for learning and memory,
for promoting cognitive function, and for their potential
to replace neurons and glial cells lost as a consequence of
brain injury or disease (Chojnacki et al., 2012; Lim and
Alvarez-Buylla, 2014; Zhao et al., 2008). Similarly, adult in-
testinal stem cells (ISCs), which reside at the bottom of the
crypt of Lieberku¨hn, constantly replenish the epithelial
sheet for a lifespan, contributing to tissue homeostasis as
well as mucosal regeneration after injury (Tetteh et al.,
2014).
Stem cells naturally reside within specific niches where
they receive local signals that maintain them in a primitive
state. The niches for each adult stem cell population differ;
thus, most of the factors that maintain tissue-specific stem
cells exert local effects restricted to that niche. Only a
limited number of juxtacrine or paracrine signaling factors
have been identified that maintain stem cells residing in
multiple niches; these include epidermal growth factor
(EGF), Notch, Wnts, fibroblast growth factors (FGFs), Shh,
and transforming growth factor b (Lander et al., 2012).St
This is an open access article under the CInsulin-like growth factor II (IGF-II) is highly expressed
in the embryo and is necessary for normal embryonic
and fetal growth (Baker et al., 1993; DeChiara et al., 1990;
Liu et al., 1993; Ren et al., 2008; Shinar et al., 1993). In
contrast, IGF-II is downregulated in most adult tissues,
with notable exceptions including the brain and the intes-
tine. In the adult CNS, IGF-II is produced by the choroid
plexus, leptomeninges, endothelial cells, and stem/progen-
itor cells in the hippocampal subgranular zone (SGZ)
(Bracko et al., 2012; Buono et al., 2015b; Ferron et al.,
2015; Logan et al., 1994a, 1994b; Stylianopoulou et al.,
1988). Due to production by the choroid plexus, IGF-II pro-
tein is found at high levels in the cerebral spinal fluid (Bunn
et al., 2005). The sites of IGF-II expression place it in close
proximity to the NSCs residing in the two major NSC
niches: the subventricular zone (SVZ) of the lateral
ventricle and the hippocampal SGZ. Moreover, although
the Igf2 gene is imprinted such that it is expressed only
from the paternal allele in most tissues (DeChiara et al.,
1991; Ferguson-Smith et al., 1991; Giannoukakis et al.,
1993), it is biallelically expressed in choroid plexus, lepto-
meninges, and brain endothelial cells (Charalambous
et al., 2004; DeChiara et al., 1991; Feil et al., 1994; Ferron
et al., 2015).
Based on the expression data and our earlier studies on
SVZ-derived neurospheres (Ziegler et al., 2012, 2014), we
hypothesized that IGF-II might be an integral componentem Cell Reports j Vol. 12 j 1–15 j April 9, 2019 j ª 2019 The Author(s). 1
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Tamoxifen-Induced Removal of
Igf2
Schematic for tamoxifen dosing in C57BL/
6 mice (A). PCR for the floxed Igf2 allele at
449 bp in iKO mice (Igf2fl/fl Cre+/) with no
tamoxifen or in WT mice (Igf2fl/fl Cre/) or
for the recombined allele at 384 bp in iKO
mice (Igf2fl/fl Cre+/) plus tamoxifen (B).
qPCR for Igf2mRNA in choroid plexus (C) and
hippocampus (D) from samples collected
2 weeks post tamoxifen administration. See
also Figure S1. Representative sections of
Luxol fast blue and H&E stains at the level of
the septal nuclei and the third ventricle of WT
and iKO mice (E and F). Statistical signifi-
cance: *p < 0.05 using ANOVA and Tukey’s
post hoc test, n = 5 WT and n = 12 iKO mice.
Error bars represent SEM. Scale bar, 1 mm.
Please cite this article in press as: Ziegler et al., Insulin-like Growth Factor II: An Essential Adult Stem Cell Niche Constituent in Brain and
Intestine, Stem Cell Reports (2019), https://doi.org/10.1016/j.stemcr.2019.02.011of the NSC niche. More recently, two studies provided sup-
port for IGF-II function in regulating NSCs; however, these
studies did not address the function of IGF-II frommultiple
sources in regulating the adult NSCs. Bracko et al. (2012)
demonstrated that Igf2 mRNA is expressed by NSCs in the
dentate gyrus (DG) but not by the NSCs in the SVZ. Thus,
short hairpin RNA knockdown of Igf2 mRNA reduced pro-
liferation ofDGNSCs but not SVZNSCs. A second report by
Ferron et al. (2015) demonstrated that deleting Igf2 system-
ically beginning embryonically reduced the number of la-
bel-retaining cells in the SVZ and SGZ in vivo. However,
loss of Igf2 embryonically significantly reduces prenatal
brain growth,making it impossible to separate the function
of IGF-II in maintaining adult NSCs from a function in
establishing NSCs during development. This study further
demonstrated that loss of Igf2 from endothelial cells
beginning embryonically partially compromises SVZ
NSCs but has no effect on the SGZ NSC population (Ferron
et al., 2015), thus raising the question as to whether IGF-II
is essential for maintaining the NSCs in the adult
hippocampus.
In the intestine, IGF-II is found in the colonic mucosa,
and Igf2 loss of imprinting (LOI) in Apcmin/+ background
increases crypt length (Sakatani et al., 2005). However,
no studies to date have established whether IGF-II is an
essential niche stem cell factor in the adult intestine.
Therefore, to address the functions of IGF-II in multiple
adult stem cell niches, we designed experiments to re-
move Igf2 in young adult mice and evaluate adult NSC
and ISC maintenance.2 Stem Cell Reports j Vol. 12 j 1–15 j April 9, 2019RESULTS
Adult NSCs Require Sustained IGF-II Production
To determine whether IGF-II is necessary for adult stem cell
homeostasis, we mated floxed Igf2 mice with a tamoxifen-
inducible Rosa 26 CreER driver mouse line (Badea et al.,
2003; Haley et al., 2012) to generate littermates for experi-
mental animals that were all Igf2fl/fl and either Cre+ or
Cre. Administering tamoxifen over 5 consecutive days
beginning at postnatal day 21 (p21) resulted in death of
Igf2 knockout (KO) mice (see below regarding this lethal
phenotype); therefore, we administered tamoxifen
(75 mg/kg) every 3 days for the studies on the CNS (Fig-
ure 1A). PCR analysis 2 weeks after tamoxifen administra-
tion showed a recombined band of the expected size indi-
cating excision of exons 4–6 of the Igf2 gene (Figure 1B).
Consistentwith these results,mRNA levels of Igf2 in choroid
plexus and hippocampus were reduced by 90% in heterozy-
gous Cre (Igf2fl/flCre+/) mice versus wild-type (WT) (Igf2fl/fl)
(Figures 1C and 1D). Since Igf2 mRNA levels were similarly
reduced inmiceheterozygous andhomozygous for Cre (Fig-
ure S1), heterozygous Cre mice were used for all in vivo
studies to exclude possible Cre toxicity (Silver and Living-
ston, 2001). Luxol fast blue with H&E staining from adult
mice 3months after Igf2 removal revealed no gross anatom-
ical changes in the brain structures surrounding the SVZ or
SGZ of the Igf2-inducible KO (iKO) mice (Figures 1E and
1F). Additionally, no differences were observed in organ
weights of the heart, lung, liver, kidney, and spleen adjusted
to total bodyweight forWTand iKOmice (data not shown).
Figure 2. IGF-II Maintains Label-Retaining Cells in the SGZ of the Hippocampus and Is Necessary for Learning and Memory
Schematic of timeline for tamoxifen administration and labeling with IdU and CldU (A). Representative images of the hippocampi of WT
(B) and iKO mice (C). Scale bars, 100 mm. IdU red, CldU green, GFAP white, and DAPI blue. (B0) and (C0) are insets from the regions marked
in (B) and (C), respectively (scale bars, 20 mm). Counts of single- and double-positive cells for CldU and IdU in the SGZ (D), n = 6 WT and
n = 6 iKO mice. See also Figures S2 and S3. Morris water maze latency to platform in seconds (E), and probe trial (F), n = 13 WT and n = 16 iKO
mice. Open field test percent time spent in center across each 5-min interval (G), and maps of typical path taken (H), n = 10 WT and
n = 15 iKO mice. WT black, iKO red. Statistical significance in (D) and (F) by Student’s t test (*p < 0.05) and repeated-measures ANOVA in
(E) and (G) (*p < 0.05). In (E), a session effect was observed in WT mice but not in iKO mice. Error bars represent SEM.
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genitors in the SGZ and SVZ, we analyzed the preservation
of label-retaining cells using temporally spaced administra-
tions of the thymidine analogs iododeoxyuridine (IdU) and
chlorodeoxyuridine (CldU) as depicted in Figure 2A (Llo-
rens-Martin and Trejo, 2011; Vega and Peterson, 2005).
Studies were performed to validate lack of cross-reactivity
in detecting IdU and CldU (Figure S2). We examined the
number of IdU and CldU single- and double-positive cells
in the SGZ and SVZ in theWTand iKOmice, where double
analog-positive cells are the label-retaining, slowly cycling,NSCs (Figures 2 and 3). Glial fibrillary acidic protein
(GFAP), which is expressed by adult NSCs in SVZ and
SGZ, was also included for analysis. Triple-positive IdU/
CldU/GFAP cells were observed in the SGZ and SVZ, along
with IdU andCldU single-positive cells (Figures 2B–2C0 and
3A–3D0) but it was difficult to establish whether a cell was
definitively GFAP+ and thymidine analog positive; there-
fore, GFAP expression was not included in the stereology
analyses. The numbers of single- and double-positive cells
for the analogs were counted using unbiased stereology
(Figures 2D and 3E). Significantly fewer IdU+/CldU+ cellsStem Cell Reports j Vol. 12 j 1–15 j April 9, 2019 3
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Table 1. Multicolor Flow Cytometry Reveals a Decrease in SVZ Neural Stem Cells after Igf2 Conditional Deletion
Cell
Type NSC MP1 MP2 GRP/MP3 MP4 PFMP BNAP GRP3
WT 1.27% ± 0.09%a 18.73% ± 2.53% 4.30% ± 1.30% 10.33% ± 1.40% 0.50% ± 0.31% 0.90% ± 0.23% 8.68% ± 1.90% 0.34% ± 0.07%
iKO 1.01% ± 0.07%*b 21.87% ± 2.02% 4.91% ± 1.46% 8.33% ± 1.30% 0.33% ± 0.21% 1.03% ± 0.19% 13.46% ± 2.30% 0.38% ± 0.06%
See also Figure S3. NSC, neural stem cell; MP1, multipotential 1; MP2, multipotential 2; MP3/GRP2, multipotential 3/glial restricted progenitor 2; PFMP,
PDGF- and FGF-responsive multipotential progenitors; BNAP/GRP1, bipotential neuronal-astrocytic precursor/glial restricted progenitor 1; GRP3, glial
restricted progenitor 3; WT, wild-type; iKO, inducible KO.
aData are presented as mean values ± SEM, n = 17 WT and 19 iKO mice of both sexes.
b*p < 0.05 by one-way ANOVA and Tukey’s post hoc test.
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ure 3E) in the iKO mice compared with WT mice, consis-
tent with an essential function for IGF-II in NSC homeosta-
sis. Concomitant with the loss of IdU+/CldU+ cells, there
was an increase in progenitors that were only CldU+ in
the iKOs attributable to maturation of NSCs into progeni-
tor cells (Figures 2D and 3E). Using a four-color flow-cytom-
etry panel established in the Levison lab (Buono et al.,
2012, 2015a), we evaluated the composition of the SVZ
12 months after Cre induction. Compared with the con-
trols there was a statistically significant reduction in the
NSCs (1.27% ± 0.09% NSCs in WT versus 1.01% ± 0.07%
in iKOs) with modest increases in the proportions of two
progenitor cell populations (Table 1). We evaluated the
extent of apoptotic death within the SVZ and SGZ using
in situ end labeling but detected no difference between
the WT and iKO mice, indicating it was unlikely that the
decrease in IdU/CldU-labeled cells in the iKO mice was
due to apoptotic cell death (Figure S3).
Several studies have correlated increased or decreased cell
proliferation in the SGZ with improvements or deficits in
learning and memory, respectively (for a review see Zhao
et al., 2008). Since Igf2 deletion altered the numbers of
dual nucleotide label-retaining cells and increased the num-
ber of CldU+ proliferating cells, we performed studies to
determine whether the Igf2 iKO mice had deficits in hippo-
campal function using the Morris water maze to test spatialFigure 3. IGF-II Is Required for SVZ NSC Maintenance, OB Neurog
WT (A and B) and iKO (C and D) mouse SVZs stained for IdU, CldU, and G
and 20 mm (A0–D0). IdU red, CldU green, GFAP white, and DAPI blue.
20 mm of the lateral ventricle wall (E), n = 6 WT and n = 6 iKO mice. Se
neurons using doublecortin (DCX, red) and DAPI (blue) in WT (F) and iK
DCX+ cells (H), n = 3 WT and n = 3 iKOmice. WT (I and K) and iKO (I0 and
stained for BrdU and NeuN, 5 weeks after administering BrdU. Arro
100 mm. Quantification of newly formed cells in the granule cell layer (
also Figure S4. Paraformaldehyde fixed and decalcified preparations of
8 mm. Sections from WT and iKO mice were stained using PAS and visual
are provided. Scale bar, 20 mm (M). Buried food test showing latency to
n = 6 iKO mice. Statistical significance: *p < 0.05 and **p < 0.005 uslearning and memory and the open field test to evaluate
exploratory activity and anxiety (Figures 2E–2H). WT mice
initially required 50 s to find the hidden platform in the
Morris water maze, but quickly learned the location of the
platform, and their latency to find the platform decreased
from 50 s to 10 s. By contrast, the iKO mice were impaired
in learning and displayed longer latencies to find the plat-
form (repeated-measures ANOVA, n = 16 iKO and n =
13 WT) (Figure 2E). To test memory retention, we tested
mice in a probe trial. WT mice swam significantly longer
(50%) in the target quadrant than the iKO mice (35%) (Fig-
ure 2F). There was no difference between genotypes in the
ability to find a visible platform (data not shown).
We further assessed the effects of losing IGF-II on explor-
atory and anxiety behavior using an open field test. Mice
were placed into an open field test apparatus andwere eval-
uated across six 5-min intervals. Overall the total distance
traveled was unaltered between WT and iKO mice (data
not shown). However, the iKO mice traveled less distance
than the WT mice in the first two intervals (iKO 1,683 ±
121 and 1,103 ± 104 versus WT 2,072 ± 129 and 1,426 ±
94), and the total time that the iKO mice were immobile
was significantly increased compared with WT mice (iKO
955.4 ± 47.7 versus WT 761 ± 64.8). What emerged most
clearly across trials was that the iKO mice avoided the cen-
ter of the arena (Figures 2G and 2H) (n = 13 iKO and n =
10 WT), indicating increased anxiety in the iKO mice.enesis, and Olfaction
FAP; insets (with primes) are enlargements. Scale bars, 100 mm (A–D)
Counts of single- and double-positive cells for CldU and IdU within
e also Figures S2 and S3. Olfactory bulb was examined for immature
O (G). Scale bars, = 100 mm. Fluorescence intensity was measured for
K0) for granule cell layer (I and I0) and periglomerular layer (K and K0)
ws indicate double-positive, newly generated neurons. Scale bars,
J) and periglomerular cell layer (L), n = 3 WT and n = 3 iKO mice. See
mouse nasal pharynxes were embedded in paraffin and sectioned at
ized by light microscopy; representative sections of WT and iKO mice
find food versus genotype (N), WT (black) and iKO (red), n = 5 WT and
ing Student’s t test, iKO versus WT. Error bars represent SEM.
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rise to neuroblasts that migrate through the rostral migra-
tory stream (RMS) to the olfactory bulb, resulting in
10,000–30,000 new neurons per day (Lledo and Sagha-
telyan, 2005). As the iKO mice had fewer IdU+/CldU+ cells
but increased CldU+ cells in the SVZ, we performed ana-
lyses to determine whether there were increased numbers
of migrating neuroblasts or new neurons in the olfactory
bulb. The relative numbers of doublecortin (DCX)-posi-
tive immature neurons in the RMS entering the olfactory
bulb were equivalent between the WT and iKO mice (Fig-
ures 3F–3H). However, using bromodeoxyuridine (BrdU)
to label dividing progenitors in the SVZ and BrdU+/
NeuN+ immunostaining to trace their differentiation
into new olfactory bulb neurons, we observed a dramatic
increase in the number of double-positive BrdU/NeuN
cells in the granule cell layer of the olfactory bulb in the
iKO mice compared with the WT mice (Figures 3I and
3J). In contrast, the number of double-positive BrdU/
NeuN cells was unchanged in the iKO periglomerular
layer of the olfactory bulb (Figures 3K and 3L). It has
been well established that the new olfactory bulb neurons
produced by the SVZ are GABAergic inhibitory interneu-
rons (Betarbet et al., 1996; Carleton et al., 2003; Kato
et al., 2001; Petreanu and Alvarez-Buylla, 2002; Winner
et al., 2002); however, we were unsuccessful in establish-
ing which subset of interneurons were overproduced as
neither calretinin, calbindin, nor tyrosine hydroxylase
stained the BrdU+/NeuN+-labeled neurons (Figure S4).
Using the buried food test as an olfaction assay, we found
that the iKO mice took twice as long as the WT mice (iKO
325 ± 24 s versus WT 146 ± 18 s) to find a buried Fruit
Loop (Figure 3N). As there are stem cells and olfactory re-
ceptor cells in the olfactory epithelium that turn over, an
involution of the olfactory epithelium could explain the
olfaction deficit; however, the morphology and structure
of the olfactory epithelium appeared unchanged in both
H&E-stained and periodic acid-Schiff (PAS)-stained sec-
tions of the iKO mice (Figure 3M). Therefore, we conclude
that the loss of IGF-II led to an increase in SVZ progenitors,
which in turn led to the overproduction of new inhibitory
neurons in the olfactory bulb, resulting in a deficit in
olfaction.
Adult ISCs Require Sustained IGF-II Production
We next asked whether IGF-II has a broader function in
maintaining other adult stem cells. We speculated that
the lethality of Igf2 iKO mice receiving five consecutive
daily doses of tamoxifen might be due to a rapid loss of
ISCs, whose differentiated progeny normally live for
3–5 days after cell-cycle exit (van der Flier and Clevers,
2009). To test this hypothesis, we analyzed the intestines
from tamoxifen-injected iKOmice and their WT littermate6 Stem Cell Reports j Vol. 12 j 1–15 j April 9, 2019controls on day 6 after tamoxifen administration. At this
time, there was an average of 15% body-weight loss in
iKO mice when compared with the WT littermates (Fig-
ure 4A). Analyses of the chemical composition of the
plasma failed to detect consistent differences between the
iKOs and WT mice; hematocrit was normal in iKOs, and
no difference was detected in leukocyte frequencies (data
not shown). However, iKO mice showed clear signs of
declining health including hunched backs, lethargy, and
reduced food/water intake (data not shown). All iKOs, if
not sacrificed at this time, would die within a week. The in-
testinal tract of the iKO mice appeared translucently pale
with dilated lumen, enlarged cecum, and no solid feces in
the colonic lumen (Figures 4B–4E). These pathological ef-
fects were not due to tamoxifen toxicity, as intestines
from the WT littermates subjected to the identical tamox-
ifen treatment appeared normal.
In situ hybridization showed that Igf2 was highly ex-
pressed in WT crypts and at lower levels in villus epithe-
lium as well as some mesenchymal cells (Figures 4F, 4F0,
and 4H). Igf2 mRNA levels were significantly reduced in
iKO intestines (Figures 4G–4H). Immunohistochemistry
for IGF-II confirmed the mRNA pattern with IGF-II protein
drastically reduced in iKO intestines, most notably in the
crypts (Figures 4I–4K).
Histological examination suggested a clear loss of villus-
crypt boundaries and a transit amplifying cell zone in iKO
intestines, where the villi became severely blunted (Figures
5A–5B0). Approximately 80% of the WT crypts had robust
expression of Olfm4, a marker of crypt-based columnar
(CBC) stem cells (Barker et al., 2007; van der Flier and
Clevers, 2009), whereas only 10%of the iKO crypts showed
detectable Olfm4 expression (Figures 5C–5E). Even when
Olfm4+ crypts were occasionally found, these crypts had
an abnormal morphology (Figure 5D, inset). Ki67+ transit
amplifying cells were abundant in WT crypts but were
significantly decreased in iKO crypts (Figures 5F–5H), sug-
gesting that loss of IGF-II caused a severe reduction of
transit amplifying and potentially stem/progenitor cell
populations.
Lysozyme-positive Paneth cells were present at the bot-
tom of the WT crypts (Figures 5I, 5I0, and 5K). In contrast,
all Paneth cells were virtually eliminated from the iKO
crypts (Figures 5J, 5J’, and 5K). Some lysozyme+ cells were
seen in the iKO villi (Figures 5J [arrowhead and inset], 5J0,
and 5K). qRT-PCR verified an overall reduction of the genes
in the iKO that are characteristic of Wnt/b-catenin
signaling and fast-cycling stem cells (Figures 5L and 5M),
as well as Paneth cells (Figure 5N) and alternative stem
cell populations (Figure 5O). These data suggested that
there was a severe impairment in the crypt compartment
affecting both stem and Paneth cell populations in iKO
mouse intestines.
Figure 4. Loss of IGF-II Abrogates Intestinal Homeostasis
Five consecutive injections of tamoxifen (75 mg/kg) were administered from day 1 to day 5 and tissues were analyzed on day 6. Body-
weight curve of WT and iKO mice from day 1 to day 6 (A), n = 3 WT and n = 4 iKO mice. WT (B and D) and iKO (C and E) guts were surgically
dissected (from the stomach to the colon) and the ceca were photographed at day 6. Scale bars, 6 inches for intestines and 200 mm for
cecum. Igf2 mRNA (F–G0) and IGF-II protein (I–J0) levels were detected in WT (F, F0, I, and I0) and iKO (G, G0, J, and J0) intestine using in
situ hybridization and immunohistochemistry, respectively. Scale bars, 200 mm. n = 3 WT and n = 3 iKO mice. *p < 0.05 by Student’s t test.
Error bars represent SEM.
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renewal capacity, we isolated intestinal crypts fromWTand
iKOmice 5 days after tamoxifen administration in vivo, and
cultured them in EGF, Noggin, and R-spondin-1 (ENR) me-
dium. WT crypts underwent continuous budding (Fig-
ure 6A), whereas few iKO crypts initiated budding (arrows
in Figure 6A). The percentage of viable iKO organoids was
significantly reduced (Figure 6B). We then performed
inducible Igf2 deletion in culture, by adding 4-hydroxyta-
moxifen (4-OHT) to the iKO organoids that already formed
in vitro. Addition of 4-OHT, but not vehicle, led to clear
regression of buds in iKO organoids at day 3 (compare
left andmiddle columns in Figure 6C). Tamoxifen-induced
genomic recombination at Igf2 locus was verified by PCR
(Figure 6D). When we supplemented the ENR medium
with IGF-II, such bud regression was prevented (right col-
umn in Figure 6C), even though similar recombination
occurred in the organoid (Figure 6D). Counting of
normal-appearing budding organoids from these cultures
indicated a rescuing effect by the exogenous IGF-II protein(Figure 6E). 5-Ethynyl-20-deoxyuridine (EdU) incorpora-
tion further suggested that 4-OHT treatment decreased
numbers of the proliferative cells in epithelial buds, which
was restored by IGF-II addition (Figures 6F and 6G). These
data collectively demonstrate that IGF-II loss reduces the
clonogenic activity of ISCs, supporting the idea that IGF-
II is essential for adult ISC maintenance.DISCUSSION
Taken altogether, our studies demonstrate that IGF-II is
necessary for the maintenance of distinct adult epithelial
stem cells in both the SVZ and SGZ of the brain and in
the intestine, thus making it an essential factor for these
stem cell niches. In these studies we removed Igf2 from
adult mice using two different tamoxifen dosing schemes,
one time a day for 5 days or one time every 3 days across
15 days. Both dosing schemes significantly reduced levels
of IGF-II; however, acutely deleting Igf2 resulted in deathStem Cell Reports j Vol. 12 j 1–15 j April 9, 2019 7
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The stem cells and proliferating progenitors in the intesti-
nal crypt failed to self-renew, lethally compromising the
functions of the gastrointestinal tract. Within a crypt,
two stem cell populations have been described: fast-cycling
and quiescent stem cells, and specific markers are available
for their identification. Lgr5 and Olfm4 mark the fast-
cycling or CBC stem cells, whereas Hopx, Bmi1, and
Lrig1mark the quiescent stem cells (Barker et al., 2007; San-
giorgi and Capecchi, 2008; Takeda et al., 2011; Yin et al.,
2014). Under certain conditions (e.g., injury, radiation),
interconversion between the two stem cell populations
has been reported, although the functional significance
of the quiescent stem cells remains under debate given
the robust expression of all quiescent stem cell markers
by Lgr5+ cells (Porter et al., 2002; Sato et al., 2011). When
ISCs were examined using the same tamoxifen administra-
tion protocol as used to study the NSCs (five doses of
tamoxifen administered every 3 days), little effect was
observed. The small intestines in the iKO mice appeared
normal upon gross inspection. However, there was a signif-
icant increase in the Ki67+ transit amplifying cell popula-
tion (p < 0.001), and a slight but nonsignificant increase
in crypts with multiple Hopx+ cells (Figure S5). These re-
sults suggest that slow deletion of Igf2 allowed alternative
intestinal epithelial cell populations, as we recently re-
ported (Yu et al., 2018), to compensate for the loss of fast-
cycling stem cells, which appear to be more sensitive to
IGF-II loss.
Igf2 deletion reduced the numbers of dual nucleotide
label-retaining cells and increased newly dividing cells
labeled for the second nucleotide (CldU) in both the SGZ
and SVZ, which correlated with behavioral deficits in the
Morris water maze, open field test, and the buried food
test. Our findings taken together with the prior studies by
Bracko et al. (2012) and Ferron et al. (2015) now reveal
that IGF-II regulates adult NSCs in both the SVZ and SGZ,
but that distinct sources of IGF-II support these two neuro-
genic niches. In the SGZ/DG, Igf2 is expressed by the NSCs
themselves, and this autocrine production is likely the
main source of IGF-II for the NSCs. Ferron et al. (2015)
demonstrated that Igf2 deletion from the endothelial
compartment has little impact on the SGZ/DG NSCs. In
the SVZ, the main sources of IGF-II that regulate the
NSCs likely are from both the choroid plexus and endothe-
lial cells (Ferron et al., 2015; Lehtinen et al., 2011). TheFigure 5. IGF-II Maintains the Morphology and Stemness of the S
Small intestine of WT and iKO mice after five consecutive injections of
Olfm4 (C–E), Ki67 (F–H), and lysozyme (I–K). qPCR analyses were perfo
(L), progenitors (M), Paneth cells (N), and quiescent stem cells (O). n
* p < 0.05, **p < 0.01, ***p < 0.001 by Student’s t test. Error bars rcomplete deletion of Igf2 in the adult brain in our study re-
sulted in a reduction in the SGZ/DG and SVZ NSCs and
likely contributed to the greater effect we saw on the neuro-
genic niches that resulted not only in a reduction in NSC
numbers but also in an increase in rapidly dividing progen-
itors. Moreover, we observed a burst of newly generated
neurons in the olfactory bulb.Whereas embryonic deletion
of Igf2 caused a reduction inNSCs in both adult niches, Fer-
ron et al. (2015) saw no concomitant increase in rapidly
dividing progenitors or in newly generated neurons in
the olfactory bulb in thesemice or inmice with endothelial
Igf2 deletion. It is possible that the embryonic deletion of
Igf2 significantly altered the initial establishment of NSCs
present in the adult SVZ, consistent with the significant
reduction in brain size in these mice.
Several studies have begun to establish a link between
IGF-II, memory, and cognitive impairment. For example,
IGF-II in the hippocampus is necessary for memory
consolidation and promotes memory enhancement (Al-
berini and Chen, 2012; Chen et al., 2011). Moreover,
IGF-II is being considered as a therapeutic target for Alz-
heimer’s disease (Mellott et al., 2014). Our studies demon-
strating that IGF-II is required for maintenance of a subset
of adult NSCs suggest that IGF-II may be important for
healthy aging and that reduced levels of IGF-II that occur
with aging (Bartke et al., 2003; Chen et al., 2008; Kelij-
man, 1991) may contribute to neurodegenerative or psy-
chiatric diseases.
Our studies demonstrating that IGF-II also is essential
for the rapidly dividing ISCs has important implications
for understanding the regulation of epithelial stem cell
renewal in the intestines as well as for understanding and
treating colorectal cancers. The rapid deletion of Igf2
impaired ISC homeostasis, as manifested by loss of CBCs
and transit amplifying cells. This phenotype was strong
in all iKO mice that received five consecutive doses of
tamoxifen. The lethality and the histopathology are remi-
niscent of Tcf4 deletion (Korinek et al., 1998; van Es
et al., 2012), conditional deletion of b-catenin (Fevr et al.,
2007; Ireland et al., 2004), or overexpression of secreted
Dickkopf-1, a Wnt inhibitor (Kuhnert et al., 2004; Pinto
et al., 2003). Redundancy exists among various Wnt pro-
teins, and there are multiple sources of Wnts in the intesti-
nal stem cell niche (Aoki et al., 2016; Farin et al., 2012;
Kabiri et al., 2014). In contrast, the phenotype presented
here that resulted from the loss of a single growth factor,
IGF-II, was striking.mall Intestine
tamoxifen (75 mg/kg) were stained and quantified for H&E (A–B0),
rmed in WT and iKO intestines to detect marker genes for stem cells
= 3 (WT) and 3 (iKO) mice. See also Figure S5. Scale bars, 200 mm.
epresent SEM.
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including colorectal cancer (CRC) (Gelato and Vassalotti,
1990; Lamonerie et al., 1995; Yee et al., 1988), and Igf2
LOI is a potential marker for CRC risk (Cui et al., 2003).
Increased allelic Igf2 expression promotes intestinal tumor
formation and hyperproliferation of crypt epitheliumwith
longer intestinal crypts (Bennett et al., 2003; Harper et al.,
2006). Overexpression of Igf2 shifts cells to a less differenti-
ated state, resulting in increased tumor initiation rather
than proliferation (Sakatani et al., 2005). Insulin receptor
substrate 1 (IRS-1), which is an intracellular mediator of
both insulin and the IGF actions, has been implicated as
an important determinant for ISC survival after injury,
and partial or absolute IRS-1 deficiency in mice carrying
the Apcmin/+ mutation led to reduced tumor number rela-
tive to IRS-1+/+/Apcmin/+ mice. Furthermore, elevated levels
of insulin correlate with both low intestinal epithelial cell
apoptosis and increased adenoma risk (Keku et al., 2005;
Ramocki et al., 2008).
Our prior published studies indicate that IGF-II promotes
SVZ NSC stemness in vitro through the A splice isoform of
the insulin receptor and independently of either the IGF
type 1 receptor (IGF-1R) or IGF-2R (Ziegler et al., 2012,
2014). Interestingly, the recent study by Bracko et al.
(2012) showed that IGF-II acted through the IGF-1R to sup-
port DG/SGZ NSCs. Thus, IGF-II may have specific effects
on the two neurogenic niches through distinct receptors
to promote cell regeneration and healthy aging. While
structurally similar, the differences in the biological effects
of IGF-I and IGF-II are significant, and our studies demon-
strate that muchmore needs to be learned about IGF-II and
how it signals through its cognate receptors to affect spe-
cific adult stem cell populations.EXPERIMENTAL PROCEDURES
Animals
All experiments were performed in accordance with protocols
approved by the institutional animal care and use committee of
Rutgers-New Jersey Medical School and in accordance with the
National Institutes of Health Guide for the Care and Use of Labo-
ratory Animals (NIH Publications No. 80-23) revised in 1996.
Mouse strains includedCreER driven off aGt(ROSA)26Sor promoter
(Gt(ROSA)26Sortm1(cre/Esr1)Nat/J) (Jax mouse stock #004847) and
floxed Igf2 mice (Haley et al., 2012). Mice were obtained asFigure 6. Igf2 Knockout Impairs the Growth of Intestinal Organo
WT and iKO (Igf2fl/flCre+/) organoids were cultured in medium contain
small organoids with few Paneth cells. Arrowhead indicates dying orga
curve of organoids from WT and iKO mice (B). 4-OHT or vehicle was ad
were imaged daily (C), harvested for genotyping (D), and scored daily (
from a Rosa26-CreER heterozygous mouse sample to show the WT (bot
at day 4 after 4-OHT treatment (F and G). Scale bars, 200 mm. *p < 0.05
way ANOVA. Data were analyzed from n = 3 independent mice. Error bC57BL/6 mixed strain and were backcrossed for five generations
onto C57BL/6 (Jackson Laboratory) prior to use. Male and female
mice, heterozygous for Cre, Gt(ROSA)26Sortm1(cre/Esr1)Nat/J and ho-
mozygous for floxed Igf2 were bred to generate mice used for the
experiments. Progeny from the cross consisted of either heterozy-
gous or homozygous Cre with homozygous floxed Igf2 (iKO) and
homozygous floxed Igf2 mouse littermates that did not carry the
Cre (WT).Tamoxifen and Nucleotide Administration
Both Cre+ (iKO) and Cre (WT) mice were administered tamoxifen
(Sigma T5648; 75mg/kg) intraperitoneally beginning at 4–5 weeks
of age according to the schedule in Figure 1 for the NSC analyses or
over 5 consecutive days for the intestinal analyses. For the NSC
analysis, mice were 54 days old (±5 days) at the start of dual analog
labeling and approximately 6 months old at tissue collection, and
were the same across genotypes. A distinct cohort of mice between
the ages of 2.5 and 6 months were used for behavioral studies. For
the ISC analyses, mice were used 5–6 days following administra-
tion of tamoxifen.Thymidine Analog Detection
IdU (Sigma I7125) or BrdU (Sigma, B5002) were provided at
1 mg/mL in 1% sucrose water. CldU (Sigma C-6891), dissolved in
0.9% saline, was administered intraperitoneally at 42.5 mg/kg.
IdU and CldU detection was performed as described by Tuttle
et al. (2010). GFAP (DAKO 1:500) was also included for analysis.
IdU was detected with Dylight 549 conjugated secondary anti-
body, CldU with Dylight 488 conjugated secondary antibody,
and GFAP with an Alexa 647 conjugated secondary antibody (all
from Jackson ImmunoResearch) alongwith 40,60-diamidino-2-phe-
nylindole (DAPI) at 1:1,000 in PBS for 15 min. Slides were cover-
slipped using Fluorogel (Electron Microscopy Sciences, #19440).Stereology
For stereology analysis, 8-mm adjacent hippocampal or 5-mm adja-
cent SVZ tissue sections stained with CldU/IdU/GFAP/DAPI were
used. Cell counts were performed using the physical fractionator
(StereoInvestigator;MBFBioscience).A systematic randomsampling
of cells within the regions of interest in adjacent sections was per-
formedbidirectionally toobtain anunbiased estimateof thenumber
of single-, double-, and triple-labeled cells. Sections were coded to
ensure blinding during image acquisition and counting.DCX, NeuN, and In Situ End Labeling Staining
DCX staining was performed using a goat polyclonal anti-DCX
(1:100, Santa Cruz Biotechnology SC 8066) as previously describedids
ing EGF, Noggin, and R-spondin1 (ENR) for 5 days. Arrows delineate
noid on day 3, which was confirmed to be dead on day 5 (A). Survival
ded to iKO (Igf2fl/flCre+/+) organoid cultures at day 7. The organoids
E). The positive control (p.c.) used in (D) is the genomic DNA sample
tom) and mutant (upper) PCR products. EdU staining was performed
, **p < 0.01, ***p < 0.001 versus controls by Student’s t test or one-
ars represent SEM.
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itive cells was quantified using ImageJ software. Sections were
stained for BrdU and NeuN as described previously (Goodus
et al., 2015). In situ end labeling was performed as described previ-
ously (Romanko et al., 2004). Imageswere taken using aQ-imaging
mono 12-bit camera interfaced with iVision 4 scientific imaging
software (Scanalytics).
For multicolor flow cytometry, WT and iKO mice were adminis-
tered tamoxifen (75mg/kg) every 3 days beginning at 4–5 weeks of
age and were euthanized at 12months of age. SVZ cells were disso-
ciated and stained using fluorescently labeled probes to the
following cell-surface antigens: CD133/LeX/NG2/CD140a. A total
of 50,000 cell events were analyzed per animal after excluding
debris and dead cells by DAPI. A two-gate strategy was used to
group cells into one of eight categories.
Behavioral Tests
Micewere tested for alterations in olfaction using a buried food test
as described by Yang and Crawley (2009). Deficits in hippocampal
function were determined using the Morris water maze to test
spatial learning and memory and the open field test to evaluate
exploratory activity and anxiety (for a review see Zhao et al.,
2008). Details of these procedures can be found in Supplemental
Experimental Procedures.
Intestinal Tissue Analyses
Small intestines were dissected and flushed with cold PBS. The
proximal halves were fixed in DEPC-treated 4% paraformaldehyde
for 1 h at room temperature, changed into 30% sucrose overnight
at 4C, frozen, and sectioned at 10 mm for in situ hybridization. The
distal halves were fixed in 4% paraformaldehyde overnight,
embedded in paraffin, and sectioned at 5 mm for immunohisto-
chemistry. In situ hybridization analysis for Igf2 andOlfm4was per-
formed as previously described (Gregorieff and Clevers, 2010; Gre-
gorieff et al., 2005). Paraffin sections were stained with H&E, for
lysozyme (1:8, Biogenex), Ki67 (1:2000, Vector Laboratories), and
Hopx (1:1,000, Santa Cruz). Frozen tissue sections were stained
for IGF-II (1:1,000, Santa Cruz) as previously described (Gao
et al., 2009). For Igf2 in situ hybridization and IGF-II immunohisto-
chemistry, individual crypts were visually scored, based on stain-
ing intensities, into none, weak, and strong categories. Percentage
of each category was presented in results. For Olfm4 in situ, crypts
with positive Olfm4 staining were manually counted and reported
from sections of intestinal tissues. For Ki67, lysozyme, and EdU
staining, numbers of positive cells were counted for individual
crypts and reported as the average number per crypt. For Hopx,
percentages of crypts containing 1, 2, or 0 strongly Hopx-positive
cells were reported. All values are presented asmeans ± SEM.Differ-
ences among groups were analyzed by Student’s t test with
GraphPad Prism version 5.01. Significance was noted when
p was less than 0.05.
Intestinal Organoid Culture
Organoids were derived from isolated crypts of the proximal small
intestine of WT and iKO mice as described previously (Sato and
Clevers, 2013; Sato et al., 2009). Organoids were maintained in
an ENR-containing medium. Organoid growth was imaged and12 Stem Cell Reports j Vol. 12 j 1–15 j April 9, 2019quantified by scoring the number of live organoids that developed
during the 5 days after isolation or treatment. For in vitro induction
of Igf2 deletion, organoidswere derived and cultured as above from
iKO (Igf2fl/flCre+/+) mice and were treated for 12 h with either
0.5 mM 4-OHT (iKO) or vehicle on day 7 as described previously
(Farin et al., 2012). EdU (Life Technologies) stainingwas performed
according to the manufacturer’s instructions. Data were analyzed
from organoids isolated from three independent mice.SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/
10.1016/j.stemcr.2019.02.011.
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